Filter your results
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation studyThe Lancet, 2015, 2 (3), pp.e108-17. ⟨10.1016/S2352-3026(15)00020-4⟩
Journal articles
inserm-02913620v1
|
||
|
A pretargeting system for tumor PET imaging and radioimmunotherapyFrontiers in Pharmacology, 2015, 6, pp.54. ⟨10.3389/fphar.2015.00054⟩
Journal articles
inserm-02913677v1
|